BBH

Equity ETFs

Disappointing Drug Trials Drag on Biotech ETFs

By Tom LydonJanuary 21, 2016

Featured

ETF Providers Diversifying with Exchange Listings

By Tom LydonJanuary 13, 2016

Contributed

ETF Chart of the Day: Hot Biotechnology Sector

By Paul Weisbruch, Street One FinancialJuly 30, 2015

Featured

Biotech Hedge Funds are hot, but Biotech ETFs are Hotter

By Todd ShriberMay 29, 2015

Featured

An ETF for Hedge Funds’ Favorite Biotechs

By Todd ShriberMay 27, 2015

Featured

Biotech ETFs are not out for Summer

By Todd ShriberMay 26, 2015

Featured

Biogen Boosts Biotech ETFs to More New Highs

By Todd ShriberMarch 20, 2015

Featured

ETFs for the Next Biotech Takeover Targets

By Todd ShriberMarch 10, 2015

Featured

A Biotech ETF Right for Oncology Mergers and Acquisitions

By Todd ShriberMarch 9, 2015

Featured

Healthcare ETFs up at Least 10% This Year

By Tom LydonFebruary 26, 2015

Featured

Healthcare ETFs Have More Room to Run

By Tom LydonFebruary 11, 2015

Featured

Gilead Could Goose Biotech ETFs

By Todd ShriberFebruary 4, 2015

Featured

‘Tis the Season for Biotech ETFs

By Todd ShriberJanuary 5, 2015

Featured

The Dominance of Health Care ETFs in One Chart

By Todd ShriberNovember 20, 2014

Featured

Biotech ETFs Prescribe New ETFs

By Todd ShriberOctober 23, 2014

Featured

Biotech ETFs Aren’t Waving the White Flag…Yet

By Tom LydonOctober 15, 2014

Featured

Biotech ETFs Look to Build on Hot August Returns

By Tom LydonSeptember 3, 2014

Featured

So Much for That Biotech ETF Bubble

By Todd ShriberAugust 20, 2014